CASE 3. Pathologic complete remission of metastatic gastrointestinal stromal tumor after imatinib mesylate.
Chacón
Matías
M
Department of Medical and Surgical Oncology, Alexander Fleming Institute, Buenos Aires, Argentina.
Roca
Enrique
E
Huertas
Eduardo
E
Loria
Fernando Sanchez
FS
Domenechini
Enzo
E
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001549:Benzamides; D046152:Gastrointestinal Stromal Tumors / Q000188:drug therapy* / Q000473:pathology*; D006801:Humans; D000068877:Imatinib Mesylate; D008297:Male; D008875:Middle Aged; D010879:Piperazines / Q000627:therapeutic use*; D011743:Pyrimidines / Q000627:therapeutic use*; D012074:Remission Induction
D000970:Antineoplastic Agents; D001549:Benzamides; D010879:Piperazines; D011743:Pyrimidines; D000068877:Imatinib Mesylate